Abstract
As cosmetic technology advances, there is an increasing need to use new active ingredients in the development of cosmetic products. In the last few years application of fullerene C60 and its derivates in cosmetics has been intensively tested. Fullerenes display a wide range of biological activities. Potent scavenging capacities against radical oxygen species (ROS) and excellent potential as biological antioxidants made fullerenes suitable active compounds in the preparation of skin rejuvenation cosmetic formulations. Currently published evidence on biological activities of fullerenes relevant for their cosmetic use and examples of published patents to illustrate application of fullerenes in cosmetic technology are presented. Future trends in the development of cosmetic formulations including fullerenes are discussed.
Keywords: Fullerene, cosmetic, biological application
Recent Patents on Biotechnology
Title: Use of Fullerenes in Cosmetics
Volume: 3 Issue: 2
Author(s): Marko Lens
Affiliation:
Keywords: Fullerene, cosmetic, biological application
Abstract: As cosmetic technology advances, there is an increasing need to use new active ingredients in the development of cosmetic products. In the last few years application of fullerene C60 and its derivates in cosmetics has been intensively tested. Fullerenes display a wide range of biological activities. Potent scavenging capacities against radical oxygen species (ROS) and excellent potential as biological antioxidants made fullerenes suitable active compounds in the preparation of skin rejuvenation cosmetic formulations. Currently published evidence on biological activities of fullerenes relevant for their cosmetic use and examples of published patents to illustrate application of fullerenes in cosmetic technology are presented. Future trends in the development of cosmetic formulations including fullerenes are discussed.
Export Options
About this article
Cite this article as:
Lens Marko, Use of Fullerenes in Cosmetics, Recent Patents on Biotechnology 2009; 3 (2) . https://dx.doi.org/10.2174/187220809788700166
DOI https://dx.doi.org/10.2174/187220809788700166 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Distinct DNA Metabolism and Anti-proliferative Effects of Goat Urine Metabolites: An Explanation for Xeno-tumor Heterogeneity
Current Chemical Biology Chronic Inflammatory Diseases: Progress and Prospect with Herbal Medicine
Current Pharmaceutical Design Developments in Synthesis of the Anti-inflammatory Drug, Celecoxib: A Review
Recent Patents on Inflammation & Allergy Drug Discovery Combining Angiogenesis Inhibitors with Radiation: Advances and Challenges in Cancer Treatment
Current Pharmaceutical Design Interplay between Epigenetics & Cancer Metabolism
Current Pharmaceutical Design Rapid Screening of Different Types of Antitumor Compound Groups from Traditional Chinese Medicine by Hollow Fiber Cell Fishing with High Performance Liquid Chromatography
Combinatorial Chemistry & High Throughput Screening Telomerase as a Cancer Target. Development of New Molecules
Current Topics in Medicinal Chemistry SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target
Current Pharmaceutical Design DNA-Damaging Anticancer Drugs – A Perspective for DNA Repair- Oriented Therapy
Current Medicinal Chemistry Pharmacokinetics and Systems Pharmacology of Anti-CD47 Macrophage Immune Checkpoint Inhibitor Hu5F9-G4
Current Pharmacogenomics and Personalized Medicine Clinical and <i>In Silico</i> Outcomes of the Expression of miR-130a-5p and miR-615-3p in Tumor Compared with Non-Tumor Adjacent Tissues of Patients with BC
Anti-Cancer Agents in Medicinal Chemistry Plant Secondary Metabolites in Cancer Chemotherapy: Where are We?
Current Pharmaceutical Biotechnology Targeting Metabolic Enzymes in Cancer – Clinical Trials Update
Current Enzyme Inhibition Update on the Development of microRNA and siRNA Molecules as Regulators of Cell Physiology
Recent Patents on DNA & Gene Sequences Alternative Splice Variants of Survivin as Potential Targets in Cancer
Current Drug Discovery Technologies Physcion and Physcion 8-O-β-D-glucopyranoside: Natural Anthraquinones with Potential Anticancer Activities
Current Drug Targets Intracellular Fate of Peptide-Mediated Delivered Cargoes
Current Pharmaceutical Design Back to the Future: COX-2 Inhibitors for Chemoprevention and Cancer Therapy
Mini-Reviews in Medicinal Chemistry Curcumin Against Malaria: From Traditional Medicine to Development of Synthetic Analogs; A Bioorganic Approach
Current Traditional Medicine Gut Inflammation: Current Update on Pathophysiology, Molecular Mechanism and Pharmacological Treatment Modalities
Current Pharmaceutical Design